1. Chan WS, Ginsberg JS. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost 2006; 4: 1673-1677. [
DOI:10.1111/j.1538-7836.2006.02026.x]
2. Mara M, Koryntova D, Rezabek K, Kapral A, Drbohlav P, Jirsova S, et al. Thromboembolic complications in patients undergoing in vitro fertilization: retrospective clinical study. Ceska Gynekol Jul 2004; 69: 312-316.
3. Grandone E, Colaizzo D, Vergura P, Cappucci F, Vecchione G, Lo Bue A, et al. Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation. Hum Reprod 2004; 19: 1796-1799. [
DOI:10.1093/humrep/deh346]
4. Mára M, Koryntová D, Rezábek K, Kaprál A, Drbohlav P, Jirsová S, Zivný J. [Thromboembolic complications in patients undergoing in vitro fertilization: retrospective clinical study] Ceska Gynekol 2004; 69: 312-316.
5. Lindquist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: A population study. Obstet Gynecol 1999; 94: 595-599.
6. Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. Arch Intern Med 1997; 157: 1522-1530 [Review]. [
DOI:10.1001/archinte.1997.00440350022002]
7. Udoff LC, Branch DW. Management of patients with antiphospholipid antibodies undergoing in vitro fertilization. J Autoimmun 2000; 15: 209-211. [
DOI:10.1006/jaut.2000.0416]
8. Chan WS, Dixon ME. The "ART" of thromboembolism: A review of assisted reproductive technology and thromboembolic complications. Throm Res 2008; 121: 713-726. [
DOI:10.1016/j.thromres.2007.05.023]
9. Baumann P, Diedrich K. Thromboembolic complications associated with reproductive endocrinologic procedures. Hematol Oncol Clin North Am 2000; 14: 431-443. [
DOI:10.1016/S0889-8588(05)70143-X]
10. Balasch J, Arroyo V, Carmona F, et al. Severe ovarian hyperstimulation syndrome: Role of peripheral vasodilation. Fertil Steril 1991; 56: 1077-1083. [
DOI:10.1016/S0015-0282(16)54720-7]
11. Colburn P, Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science 1978; 201:817-819. [
DOI:10.1126/science.684408]
12. Aune B, Oian P, Osterud B. Enhanced sensitivity of the extrinsic coagulation system during ovarian stimulation for in-vitro fertilization. Hum Reprod 1993; 8: 1349-1352. [
DOI:10.1093/oxfordjournals.humrep.a138259]
13. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil Steril Dec 1995; 64:1207-1209. [
DOI:10.1016/S0015-0282(16)57987-4]
14. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, TanakaT. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril 1996; 66: 417-424. [
DOI:10.1016/S0015-0282(16)58512-4]
15. 15: Golan A, Ron-el R, Herman A, et al: Ovarian hyperstimulation syndrome: An update review. Obstet Gynecol Surv1989; 44: 430-440.
16. Ogawa S, Minakami H, Araki S, Ohno T, Motoyama M, Shibahara H, et al. A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome. J Assist Reprod Genet 2001; 18: 114-119. [
DOI:10.1023/A:1026590910462]
17. Rogolino A, Coccia ME, Fedi S, Gori AM, Cellai AP, Scarselli GF, et al. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagul Fibrinolysis 2003; 14: 277-282. [
DOI:10.1097/01.mbc.0000061296.28953.d0]
18. Rao AK, Chitkara U, Milki AA. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report. Hum Reprod 2005; 20: 3307-3312. [
DOI:10.1093/humrep/dei235]
19. Ou YC, Kao YL, Lai SL, Kung FT, Huang FJ, Chang SY, Chang Chien CC. Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: case report. Hum Reprod 2003; 18: 2375-2381. [
DOI:10.1093/humrep/deg470]
20. Ludwig M, Felberbaum RE, Diedrich K. Deep vein thrombosis during administration of HMG for ovarian stimulation. Arch Gynecol Obstet 2000; 263: 139-141. [
DOI:10.1007/s004040050014]
21. Edris F, Kerner CM, Feyles V, Leung A, Power S. Successful management of an extensive intracranial sinus thrombosis in a patient undergoing IVF: Case report and review of literature. Fertil Steril 2007; 88: 705: e9-14. [
DOI:10.1016/j.fertnstert.2006.12.024]
22. Hignett M, Spence JE, Claman P. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. Hum Reprod 1995; 10: 3121-3123. [
DOI:10.1093/oxfordjournals.humrep.a135870]
23. Horstkamp B, Lubke M, Kentenich H, Riess H, Buscher U, Lichtenegger W. Internal jugular vein thrombosis caused by resistance to activated protein C as a complication of ovarian hyperstimulation after in-vitro fertilization. Hum Reprod 1996; 11: 280-282. [
DOI:10.1093/HUMREP/11.2.280]
24. Mancini A, Milardi D, Di Pietro ML, Giacchi E, Spagnolo AG, Di Donna V, et al. A case of forearm amputation after ovarian stimulation for in vitro fertilization-embryo transfer. Fertil Steril 2001; 76: 198-200. [
DOI:10.1016/S0015-0282(01)01855-6]
25. Nelson SM, Greer IA. The potential role of heparin in assisted conception. Human Reproduction Update 2008; 14: 623-645. doi:10.1093/humupd/dmn031. [
DOI:10.1093/humupd/dmn031]
26. Saadatnia M, Zare M, Fatehi F, Ahmadi A. The effect of fasting on cerebral venous and dural sinus thrombosis. Neurol Res 2009; 31: 794-798. [
DOI:10.1179/016164109X12445505689481]